Jagsonpal Pharmaceuticals Limited (BOM: 507789)
India
· Delayed Price · Currency is INR 655.25
0.00 (0.00%)
At close: Jan 3, 2025
Jagsonpal Pharmaceuticals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Operating Revenue | 2,269 | 2,087 | 2,367 | 2,176 | 1,879 | 1,586 | Upgrade
|
| Revenue | 2,269 | 2,087 | 2,367 | 2,176 | 1,879 | 1,586 | Upgrade
|
| Revenue Growth (YoY) | -2.88% | -11.83% | 8.79% | 15.77% | 18.53% | -4.95% | Upgrade
|
| Cost of Revenue | 864.72 | 805.48 | 926.98 | 896.91 | 812.37 | 566.32 | Upgrade
|
| Gross Profit | 1,404 | 1,282 | 1,440 | 1,279 | 1,067 | 1,019 | Upgrade
|
| Selling, General & Admin | 692.73 | 632.64 | 729.76 | 703.71 | 658.72 | 687.34 | Upgrade
|
| Other Operating Expenses | 280.12 | 274.83 | 269.53 | 319.67 | 209.64 | 246.7 | Upgrade
|
| Operating Expenses | 1,118 | 1,065 | 1,101 | 1,039 | 879.22 | 945.33 | Upgrade
|
| Operating Income | 286.23 | 216.67 | 338.85 | 239.87 | 187.86 | 74.03 | Upgrade
|
| Interest Expense | -8.5 | -7.77 | -2.78 | -2.61 | -4.28 | -3.83 | Upgrade
|
| Interest & Investment Income | 85.92 | 85.92 | 34.28 | 15.46 | 29.92 | 21.68 | Upgrade
|
| Other Non Operating Income (Expenses) | -7.86 | 3.87 | 3.11 | 1.5 | 5.21 | 2.43 | Upgrade
|
| EBT Excluding Unusual Items | 355.79 | 298.69 | 373.46 | 254.22 | 218.72 | 94.31 | Upgrade
|
| Impairment of Goodwill | - | - | -0.3 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 5.92 | 11.35 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 3.59 | 0.85 | - | -0.16 | Upgrade
|
| Asset Writedown | - | - | -27.79 | - | - | - | Upgrade
|
| Other Unusual Items | -32.85 | - | -6.8 | - | - | - | Upgrade
|
| Pretax Income | 322.94 | 298.69 | 348.08 | 266.42 | 218.72 | 94.15 | Upgrade
|
| Income Tax Expense | 79.94 | 74.06 | 80.87 | 77.87 | 48.14 | 15.44 | Upgrade
|
| Net Income | 243 | 224.63 | 267.21 | 188.55 | 170.58 | 78.71 | Upgrade
|
| Net Income to Common | 243 | 224.63 | 267.21 | 188.55 | 170.58 | 78.71 | Upgrade
|
| Net Income Growth | -14.25% | -15.94% | 41.72% | 10.53% | 116.73% | 9.07% | Upgrade
|
| Shares Outstanding (Basic) | 27 | 26 | 26 | 26 | 26 | 26 | Upgrade
|
| Shares Outstanding (Diluted) | 27 | 27 | 26 | 26 | 26 | 26 | Upgrade
|
| Shares Change (YoY) | 2.38% | 1.35% | - | - | - | - | Upgrade
|
| EPS (Basic) | 9.12 | 8.49 | 10.20 | 7.20 | 6.51 | 3.00 | Upgrade
|
| EPS (Diluted) | 9.04 | 8.46 | 10.20 | 7.20 | 6.51 | 3.00 | Upgrade
|
| EPS Growth | -16.25% | -17.06% | 41.72% | 10.55% | 117.00% | 9.09% | Upgrade
|
| Free Cash Flow | 572.58 | 349.18 | 463.37 | 58.65 | 277.53 | 100.31 | Upgrade
|
| Free Cash Flow Per Share | 21.30 | 13.15 | 17.69 | 2.24 | 10.59 | 3.83 | Upgrade
|
| Dividend Per Share | - | 5.000 | 5.000 | 4.000 | 1.000 | 0.500 | Upgrade
|
| Dividend Growth | - | 0% | 25.00% | 300.00% | 100.00% | 100.00% | Upgrade
|
| Gross Margin | 61.88% | 61.41% | 60.84% | 58.78% | 56.78% | 64.29% | Upgrade
|
| Operating Margin | 12.62% | 10.38% | 14.31% | 11.02% | 10.00% | 4.67% | Upgrade
|
| Profit Margin | 10.71% | 10.76% | 11.29% | 8.67% | 9.08% | 4.96% | Upgrade
|
| Free Cash Flow Margin | 25.24% | 16.73% | 19.58% | 2.70% | 14.77% | 6.33% | Upgrade
|
| EBITDA | 316.94 | 221.73 | 347.11 | 255.13 | 198.72 | 85.33 | Upgrade
|
| EBITDA Margin | 13.97% | 10.62% | 14.66% | 11.73% | 10.57% | 5.38% | Upgrade
|
| D&A For EBITDA | 30.71 | 5.06 | 8.26 | 15.26 | 10.86 | 11.3 | Upgrade
|
| EBIT | 286.23 | 216.67 | 338.85 | 239.87 | 187.86 | 74.03 | Upgrade
|
| EBIT Margin | 12.62% | 10.38% | 14.31% | 11.02% | 10.00% | 4.67% | Upgrade
|
| Effective Tax Rate | 24.75% | 24.79% | 23.23% | 29.23% | 22.01% | 16.40% | Upgrade
|
| Revenue as Reported | 2,350 | 2,180 | 2,424 | 2,210 | 1,923 | 1,611 | Upgrade
|
| Advertising Expenses | - | 138.58 | 147.3 | 102.19 | 96.22 | 162.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.